PRUEBA RÁPIDA COMBINADA DE DETECCIÓN DE COVID E INFLUENZA.
Mexico·Clase II·III. Agentes de
diagnóstico·DIINSEL, S.A. DE C.V.·Registered April 05, 2024- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- FASTEP® COVID-19 & INFLUENZA A/B ANTIGEN COMBO TEST DEVICE.
- Trade Name (English)
- FASTEP® COVID-19 & INFLUENZA A/B ANTIGEN COMBO TEST DEVICE.
- Analysis ID
- 0948R2024 SSA
- Registration Date
- April 05, 2024
- Name (Spanish)
- DIINSEL, S.A. DE C.V.
- Name (English)
- DIINSEL, S.A. DE C.V.
Access comprehensive regulatory information for PRUEBA RÁPIDA COMBINADA DE DETECCIÓN DE COVID E INFLUENZA. (PRUEBA RÁPIDA COMBINADA DE DETECCIÓN DE COVID E INFLUENZA.) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 0948R2024 SSA and manufactured by DIINSEL, S.A. DE C.V.. The device was registered on April 05, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.